Colors for chromogenic IHC and ISH staining with multi-dye quinone methide and tyramide conjugates

US12130284B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12130284-B2
Application numberUS-202117318541-A
CountryUS
Kind codeB2
Filing dateMay 12, 2021
Priority dateJun 28, 2016
Publication dateOct 29, 2024
Grant dateOct 29, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed herein are novel chromogenic conjugates, the conjugates comprising at least two detectable moieties.

First claim

Opening claim text (preview).

The invention claimed is: 1. A multi-dye conjugate comprising a tissue reactive moiety and at least two chromophores, wherein the tissue reactive moiety is a quinone methide precursor moiety and wherein the at least two chromophores are different; wherein the at least two chromophores of the multi-dye conjugate are covalently conjugated to a heterobifunctional linker or a polyamine linker having between 2 and 10 amine groups, and wherein the heterobifunctional linker or the polyamine linker is covalently conjugated to the quinone methide precursor moiety, and wherein the quinone methide precursor moiety has the structure of Formula (II): wherein R 1 is a group selected from phosphate, amide, nitro, urea, sulfate, methyl, ester, beta-lactam, or a sugar; R 2 is a halide; R 3 , R 4 , R 5 , and R 6 are independently selected from hydrogen or an aliphatic group having between 1 and 4 carbon atoms; and R 7 is —(CH 2 ) w NH—, —O(CH 2 ) w NH—, —N(H)C(O)(CH 2 ) w NH—, —C(O)N(H)(CH 2 ) w NH—, —(CH 2 ) w O—, —O(CH 2 ) w O—, —O(CH 2 CH 2 O) w —, —N(H)C(O)(CH 2 ) w O—, —C(O)N(H)(CH 2 ) w O—, —C(o)N(H)(CH 2 CH 2 O) w —, —(CH 2 ) w S—, —O(CH 2 ) w S—, —N(H)C(O)(CH 2 ) w S—, —C(O)N(H)(CH 2 ) w S—, —(CH 2 ) w NH—, —C(O)N(H)(CH 2 CH 2 O) w CH 2 CH 2 NH, —C(O)(CH 2 CH 2 O) w CH 2 CH 2 NH—, —C(O)N(H)(CH 2 )NHC(O)CH(CH 3 )(CH 2 ) w NH—, or —N(H)(CH 2 ) w NH—, where w is an integer ranging from 1 to 12; and wherein the wavy line indicates covalent linkage point of the heterobifunctional linker or the polyamine linker. 2. The multi-dye conjugate of claim 1 , wherein the at least two chromophores are selected from the group consisting of TAMRA, Dabsyl, Cy5, Dabcyl, Cy3, Cy7, Cy3.5, Cy3B, Cy5.5, rhodamine 800, fluorescein, and derivatives or analogs thereof. 3. The multi-dye conjugate of claim 1 , wherein a first of the at least two chromophores comprises a yellow or a yellow-like color. 4. The multi-dye conjugate of claim 1 , wherein a second of the at least two chromophores comprises a cyan or a cyan-like color. 5. The multi-dye conjugate of claim 1 , wherein a first of the at least two chromophores comprises a rhodamine or a derivative or an analog thereof. 6. The multi-dye conjugate of claim 5 , wherein the rhodamine or the derivative or analog thereof comprises rhodamine 800. 7. The multi-dye conjugate of claim 6 , wherein a second of the at least two chromophores is selected from the group consisting of TAMRA or a derivative or an analog thereof, Dabsyl or a derivative or an analog thereof, Cy5 or a derivative or an analog thereof, Dabcyl or a derivative or an analog thereof, Cy3 or a derivative or an analog thereof, Cy7 or a derivative or an analog thereof, Cy3.5 or a derivative or an analog thereof, Cy3B or a derivative or an analog thereof, Cy5.5 or a derivative or an analog thereof, and fluorescein or a derivative or an analog thereof. 8. The multi-dye conjugate of claim 1 , wherein a first of the at least two chromophores comprises Cy5 or a derivative or an analog thereof. 9. The multi-dye conjugate of claim 8 , wherein a second of the at least two chromophores is selected from the group consisting of a rhodamine or a derivative or an analog thereof, Dabsyl or a derivative or an analog thereof, TAMRA or a derivative or an analog thereof, Dabcyl or a derivative or an analog thereof, Cy3 or a derivative or an analog thereof, Cy7 or a derivative or an analog thereof, Cy3.5 or a derivative or an analog thereof, Cy3B or a derivative or an analog thereof, Cy5.5 or a derivative or an analog thereof, and fluorescein or a derivative or an analog thereof. 10. The multi-dye conjugate of claim 1 , wherein the heterobifunctional linker or the polyamine linker comprises a molecular weight ranging from between about 50 g/mol to about 300 g/mol. 11. The multi-dye conjugate of claim 1 , wherein the heterobifunctional linker or the polyamine linker is derived from lysine or a derivative or analog thereof. 12. A conjugate comprising (i) quinone methide precursor moiety, (ii) a rhodamine or a derivative or an analog thereof, and (iii) Cy5 or a derivative or an analog thereof; wherein the rhodamine or the derivative or the analog thereof and the Cy5 or the derivative or the analog thereof are conjugated to a heterobifunctional or a polyamine linker having between 2 and 10 amine groups, and wherein the heterobifunctional linker or the polyamine linker is covalently conjugated to the quinone methide precursor moiety; and wherein the quinone methide precursor moiety has the structure of Formula (II): wherein R 1 is a group selected from phosphate, amide, nitro, urea, sulfate, methyl, ester, beta-lactam, or a sugar; R 2 is a halide; R 3 , R 4 , R 5 , and R 6 are independently selected from hydrogen or an aliphatic group having between 1 and 4 carbon atoms; and R 7 is —(CH 2 ) w NH—, —O(CH 2 ) w NH—, —N(H)C(O)(CH 2 ) w NH—, —C(O)N(H)(CH 2 ) w NH—, —(CH 2 ) w O—, —O(CH 2 ) w O—, —O(CH 2 CH 2 O) w —, —N(H)C(O)(CH 2 ) w O—, —C(O)N(H)(CH 2 ) w O—, —C(o)N(H)(CH 2 CH 2 O) w —, —(CH 2 ) w S—, —O(CH 2 ) w S—, —N(H)C(O)(CH 2 ) w S—, —C(O)N(H)(CH 2 ) w S—, —(CH 2 ) w NH—, —C(O)N(H)(CH 2 CH 2 O) w CH 2 CH 2 NH, —C(O)(CH 2 CH 2 O) w CH 2 CH 2 NH—, —C(O)N(H)(CH 2 )NHC(O)CH(CH 3 )(CH 2 ) w NH—, or —N(H)(CH 2 ) w NH—, where w is an integer ranging from 1 to 12; and wherein the wavy line indicates covalent linkage point of the heterobifunctional linker or the polyamine linker . 13. The conjugate of claim 12 , wherein the rhodamine or the derivative or the analog thereof and the Cy5 or the derivative or the analog thereof are conjugated to the tissue reactive moiety through a multi-functional linker, wherein the multi-functional linker comprises a molecular weight ranging from between about 50 g/mol to about 300 g/mol. 14. The conjugate of claim 13 , wherein the multi-functional linker is derived from lysine or a derivative or analog thereof. 15. The conjugate of claim 12 , wherein the rhodamine or the derivative or the analog thereof comprises rhodamine 800. 16. A multi-dye conjugate comprising a tissue reactive moiety and at least two different chromophores, wherein the tissue reactive moiety is a quinone methide precursor moiety and the multi-dye conjugate produces a green or green-like color; wherein the at least two different chromophores of the multi-dye conjugate are covalently conjugated to a heterobifunctional linker or a polyamine linker having between 2 and 10 amine groups, and wherein the heterobifunctional linker or the polyamine linker is covalently conjugated to the quinone methide precursor moiety; and wherein the quinone methide precursor moiety has the structure of Formula (II): wherein R 1 is a group selected from phosphate, amide, nitro, urea, sulfate, methyl, ester, beta-lactam, or a sugar; R 2 is a halide; R 3 , R 4 , R 5 , and R 6 are independently selected from hydrogen or an aliphatic group having between 1 and 4 carbon atoms; and R 7 is -(CH 2 ) w NH—, —O(CH 2 ) w NH—, —N(H)C(O)(CH 2 ) w NH—, —C(O)N(H)(CH 2 ) w NH—, —(CH 2 ) w O—, —O(CH 2 ) w O—, —O(CH 2 CH 2 O) w —, —N(H)C(O)(CH 2 ) w O—, —C(O)N(H)(CH 2 ) w O—, —C(o)N(H)(CH 2 CH 2 O) w —, -(CH 2 ) w S—, —O(CH 2 ) w S—, —N(H)C(O)(CH 2 ) w S—,

Assignees

Inventors

Classifications

  • five >CH- groups · CPC title

  • C09B11/24Primary

    Phthaleins containing amino groups {; Phthalanes; Fluoranes; Phthalides; Rhodamine dyes; Phthaleins having heterocyclic aryl rings; Lactone or lactame forms of triarylmethane dyes} · CPC title

  • Production of labelled immunochemicals · CPC title

  • with non-fluorescent dye label · CPC title

  • with fluorescent label · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12130284B2 cover?
Disclosed herein are novel chromogenic conjugates, the conjugates comprising at least two detectable moieties.
Who is the assignee on this patent?
Ventana Med Syst Inc
What technology area does this patent fall under?
Primary CPC classification C09B11/24. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).